The Institute of Inorganic Chemistry of the University of Vienna offers a position for a PraeDoc in the area of (metal-based) anticancer drug development in a challenging scientific environment and a great working atmosphere. Aim is the synthesis of novel anticancer drugs with higher tumor selectivity to reduce adverse effects and increase efficacy. The strongly interdisciplinary project will be carried out as part of the “Translational Cancer Therapy Research” cluster in close cooperation with the Institute of Cancer Research at the Medical University of Vienna ( All expertise and state-of-the-art facilities are available within this cluster to develop next-generation anticancer therapeutics.


Extent of Employment: 30 hours/week

Job grading in accordance with collective bargaining agreement: §48 VwGr. B1 Grundstufe (praedoc). Gross salary of ~37.500 Euro/year (net ~27.800 Euro/year).


Job Description:

Accomplishment of research projects in the area of (metal-based) anticancer drug development mainly focused on the synthesis of tumor-inhibiting compounds (Pt(IV) complexes) and additionally analytical investigations in biologically relevant media (HPLC-MS). The synthetic research work will take place in close coordination with experts in molecular biology and cell biology in order to enable the optimal design of the potential cancer therapeutics.



MSc degree in chemistry preferably in organic or inorganic synthetic chemistry (or equivalent qualification), experience in the field of synthetic chemistry, especially the synthesis and characterisation of (metal-based) anticancer compounds.

Experience in the field of NMR-spectroscopy, analytical HPLC(-MS) as well as preparative HPLC, excellent command of English. Team player, experience in academic teaching. Profound verbal and written skills.



Applications including a Curriculum vitae and a letter of motivation should be sent to Prof. Christian Kowol; christian.kowol(at)

Nach oben scrollen